Skip to main navigation Skip to search Skip to main content

Synthesis and α-Amylase Inhibition Studies of Some Coumarin Derivatives

  • M. Shivaprasad Shetty
  • , H. S. Anil Kumar
  • , N. V. Anil Kumar*
  • *Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    Abstract

    A series of nine molecules of coumarin hydrazone derivatives have been synthesized. The purpose of this study was to investigate the anti-diabetic activity of synthesized coumarin derivatives by inhibition of α-amylase enzyme isolated from Aspergillus niger microbial strain. The experiment was conducted by taking 5, 10, 50, and 100 μg/mL of each compound and acarbose as a positive control. The tests showed that compounds 3f (IC50 = 49.70 μg/mL), 3g (IC50 = 79.20 μg/mL), and 3i (IC50 = 48.80 μg/mL) as well as reference drug (IC50 = 81.70 μg/mL) exhibited inhibition activity against the enzyme. The synthesized compounds may be helpful in controlling the glucose level as α-amylase is one of the causes of increased sugar level in human body.

    Original languageEnglish
    Pages (from-to)526-530
    Number of pages5
    JournalPharmaceutical Chemistry Journal
    Volume52
    Issue number6
    DOIs
    Publication statusPublished - 01-09-2018

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    All Science Journal Classification (ASJC) codes

    • Pharmacology
    • Drug Discovery

    Fingerprint

    Dive into the research topics of 'Synthesis and α-Amylase Inhibition Studies of Some Coumarin Derivatives'. Together they form a unique fingerprint.

    Cite this